Guido Magni

Directeur/Membre du Conseil chez Anabasis SRL

Profil

Guido Magni currently works at Biotie Therapies AG, as Director, Anabasis SRL, as Director, Nouscom AG, as Director from 2020, Nouscom Srl, as Director, and AM-Pharma Holding BV, as Member-Supervisory Board.
Dr. Magni also formerly worked at Adolor Corp., as Independent Director, Biotie Therapies Oy, as Independent Director, Aprea Therapeutics AB, as Director from 2016 to 2020, Versant EuroVentures, as Managing Director, Tarveda Therapeutics, Inc., as Director, Gensight Biologics SA, as Director from 2013 to 2019, PIQUR Therapeutics AG, as Director, Mosaic Biomedicals SL, as Director, LAVA Therapeutics NV, as Non-Executive Director from 2021 to 2023, Aprea Therapeutics, Inc., as Independent Director from 2016 to 2020, Roche Holding AG, as Head-Medical Science & Global Drug Development, Synosia Therapeutics AG, as Member-Management Board, Hoffmann-La Roche, Inc., as Global Head-Medical Science Division in 2008, Aravis AG, as Managing Partner from 2011 to 2013, AM-Pharma BV, as Member-Supervisory Board, and Versant Ventures (Switzerland) GmbH, as Partner.
Dr. Magni received his doctorate degree in 1981 from The American University of Rome and doctorate degree in 1977 from the University of Padua.

Postes actifs de Guido Magni

Sociétés	Poste	Début
Anabasis SRL	Directeur/Membre du Conseil	-
AM-Pharma Holding BV	Directeur/Membre du Conseil	-
Nouscom AG	Directeur/Membre du Conseil	11/12/2020
Biotie Therapies AG	Directeur/Membre du Conseil	-
Nouscom Srl	Directeur/Membre du Conseil	-

Anciens postes connus de Guido Magni

Sociétés	Poste	Fin
LAVA THERAPEUTICS N.V.	Directeur/Membre du Conseil	01/01/2023
Aprea Therapeutics AB	Directeur/Membre du Conseil	30/06/2020
APREA THERAPEUTICS, INC.	Directeur/Membre du Conseil	30/06/2020
GENSIGHT BIOLOGICS S.A.	Directeur/Membre du Conseil	24/04/2019
░░░░░░ ░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░